DOJ questions ex-UnitedHealth doctors in probe into Medicare fraud: report
The investigation, which dates back to at least last summer, concerns alleged efforts to encourage staffers to record certain diagnoses that trigger higher payments under Medicare Advantage, accord...
UnitedHealth Group (UNH) Advances While Market Declines: Some Information for Investors
UnitedHealth Group (UNH) concluded the recent trading session at $307.7, signifying a +1.31% move from its prior day's close.
UnitedHealth Under Fire as Medicaid & Centene Bombshell Rattle Sector
UNH and peers tumble as Medicaid cuts, enrollment shifts and rising costs shake up the managed care sector.
UnitedHealth: My Uncomfortable Buy With Possible Upside Despite All The Red Flags
UnitedHealth Group faces multiple headwinds: soaring medical costs, leadership changes, regulatory scrutiny, and reputational issues—creating significant uncertainty. Despite these challenges, the ...
UnitedHealth: Cheap, But Is It Worth It?
UnitedHealth Group operates through UnitedHealthcare (insurance) and Optum (health services, tech, pharmacy), making it a global healthcare leader. Shares have plummeted over 40% in 2025, reflectin...
This Dirt Cheap Healthcare Stock Could Be a Hidden Artificial Intelligence (AI) Opportunity (Hint: It's Not Eli Lilly)
When it comes to popular healthcare stocks, investors have focused a lot of attention lately on Eli Lilly and Novo Nordisk and the potential of their blockbuster weight management treatments, inclu...
This Dividend Growth Stock Is Down 50%. Back Up the Truck or Put It in Park and Wait?
Key Points in This Article: UnitedHealth Group (UNH) has plummeted nearly 52% from its April peak, driven by a rare series of cataclysmic events.
Why The Market Is Wrong About UnitedHealth Group
The market is overestimating the negative impact of policy crackdowns, DoJ investigations, and Medicare/Medicaid cuts on UnitedHealth Group's long-term fundamentals. While legislative and regulator...
UnitedHealth: At Rock Bottom The Only Way Is Up
Despite a rare earnings miss, CEO departure, DOJ investigation, and guidance withdrawal, we view UNH as a strong long-term buy at current depressed valuations. UNH's robust balance sheet, healthy d...
UnitedHealth Group (UNH) Rises Higher Than Market: Key Facts
UnitedHealth Group (UNH) reached $305.75 at the closing of the latest trading day, reflecting a +1.68% change compared to its last close.
UnitedHealth's insider stock buys spike 3,000%
Although UnitedHealth's (NYSE: UNH) stock has plummeted 40% in 2025, insider confidence in the company has surged to new highs, with executive purchases of shares spiking by nearly 3,000%.
Congress is relentlessly buying UnitedHealth stock despite $40% drop; What's the catch?
UnitedHealth Group (NYSE: UNH) stock has had a rough ride in 2025, plunging 40% year-to-date. Despite the turmoil, members of Congress have continued to buy shares.
UnitedHealth: Diversity Is The Key To Hedging Against Looming Challenges
I'm bullish on UNH due to its diversified business model, driving strong revenue growth and resilience amid Medicaid budget cuts and sector volatility. Despite federal healthcare cuts, UnitedHealth...
After Plummeting 40%, Where Will UnitedHealth Group Stock Be in 1 Year? Here Is What History Suggests.
UnitedHealth Group (UNH 0.49%) has been one of the more interesting case studies in the stock market this year. Many stocks that have witnessed plummeting share prices can point to President Donald...
Related Companies